Cardiomyopathy: Clinical Trials

5 trials for Cardiomyopathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 35Completed 5
Phase 21Completed 1

Follow Cardiomyopathy: new trials by email Literature Review of Cardiomyopathy trials Research Report on Cardiomyopathy

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nebivolol for the Prevention of Left Ventricular Systolic Dysfunction in Patients With Duchenne Muscular Dystrophy
Nebivolol, Placebo - Duchenne Muscular Dystrophy, Cardiomyopathy
Phase 3CompletedAssistance Publique - Hôpitaux de Paris512012-02-132025-11-20
Clinical Outcomes Related to Cardiac Resynchronization Therapy Deactivation of Super Responders
Cardiac Resynchronization Therapy Device - Cardiomyopathy
Phase 2 / Phase 3CompletedYuksek Ihtisas Hospital192009-01-012014-09-25
Comparison of Inhaled Nitric Oxide and Oxygen in Participants Reactivity During Acute Pulmonary Vasodilator Testing
Nitric Oxide for inhalation, Oxygen, Nitric Oxide plus Oxygen - Idiopathic Pulmonary Arterial Hypertension, Cardiomyopathy
Phase 3CompletedMallinckrodt1362004-09-012019-12-20
Biventricular Pacing In Patients With Left Ventricular Dysfunction After Cardiovascular Surgery
Atrial synchronous bi-ventricular pacing - Cardiomyopathy, Heart Failure, Congestive
Phase 3CompletedCorewell Health East402004-08-012011-04-05
Brain Natriuretic Peptide (BNP) to Preserve Renal Function in Hospitalized Patients With Heart Failure
Nesiritide - Kidney Diseases, Congestive Heart Failure
Phase 3CompletedMayo Clinic1042003-03-012009-11-16

Narrower conditions

Cardiomyopathies (5)  ·  Heart Failure (4)  ·  Acute Lung Injury (1)  ·  Familial Primary Pulmonary Hypertension (1)  ·  Heart Defects, Congenital (1)  ·  Kidney Diseases (1)  ·  Muscular Dystrophy, Duchenne (1)  ·  Renal Insufficiency (1)

Broader conditions

Cardiovascular Diseases (5)  ·  Heart Diseases (5)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Cardiovascular Abnormalities (1)  ·  Congenital Abnormalities (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genetic Diseases, Inborn (1)  ·  Genetic Diseases, X-Linked (1)  ·  Hypertension, Pulmonary (1)  ·  Lung Diseases (1)  ·  Lung Injury (1)  ·  Male Urogenital Diseases (1)  ·  Muscular Diseases (1)  ·  Muscular Disorders, Atrophic (1)

Interventions

Cardiac Resynchronization Therapy Devices (1)  ·  Endothelium-Dependent Relaxing Factors (1)  ·  Inhalation (1)  ·  Natriuretic Peptide, Brain (1)  ·  Nebivolol (1)  ·  Nitric Oxide (1)  ·  Oxygen (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Corewell Health East (1)  ·  Mallinckrodt (1)  ·  Mayo Clinic (1)  ·  Yuksek Ihtisas Hospital (1)

Countries

United States (3)  ·  France (2)  ·  Netherlands (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

David E Haines, MD (1)  ·  Margaret M. Redfield, M.D. (1)  ·  Rudolph F Evonich, MD (1)  ·  Serkan Cay, MD (1)

Results publications

PMID 20405117

NIH funding

2004 (1)